BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19248693)

  • 1. Underutilization of angiotensin converting enzyme inhibitors among heart failure patients.
    Lean QY; Shamsuddin N; Wan Ahmad WA
    Med J Malaysia; 2008 Aug; 63(3):216-21. PubMed ID: 19248693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
    Brackbill ML; Bashaw-Keaton R; Sytsma CS
    Am J Manag Care; 2007 Oct; 13(10):568-70. PubMed ID: 17927461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Levy PD; Nandyal D; Welch RD; Sun JL; Pieper K; Ghali JK; Fonarow GC; Gheorghiade M; O'Connor CM
    Am Heart J; 2010 Feb; 159(2):222-230.e2. PubMed ID: 20152220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA; Hussein GM; Hamza EA
    Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.
    Setoguchi S; Levin R; Winkelmayer WC
    Int J Cardiol; 2008 Apr; 125(2):172-7. PubMed ID: 17997175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
    Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
    Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
    Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.
    Butler J; Forman DE; Abraham WT; Gottlieb SS; Loh E; Massie BM; O'Connor CM; Rich MW; Stevenson LW; Wang Y; Young JB; Krumholz HM
    Am Heart J; 2004 Feb; 147(2):331-8. PubMed ID: 14760333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge.
    Butler J; Arbogast PG; Daugherty J; Jain MK; Ray WA; Griffin MR
    J Am Coll Cardiol; 2004 Jun; 43(11):2036-43. PubMed ID: 15172409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.
    Wawruch M; Slezakova V; Murin J; Luha J; Bozik M; Leitmann T; Kuzelova M; Shah R
    Aging Clin Exp Res; 2014 Jun; 26(3):307-14. PubMed ID: 24781831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal insufficiency and treatment of persistent cardiac insufficiency with converting enzyme inhibitor].
    Chamontin B; Begasse F; Salva P; Salvador M
    Therapie; 1989; 44(1):29-32. PubMed ID: 2734717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and morbidity of non-systolic heart failure treated with angiotensin-converting enzyme inhibitors: a propensity-adjusted case-control study.
    Gomez-Soto FM; Romero SP; Bernal JA; Escobar MA; Puerto JL; Andrey JL; Almenara J; Gomez F
    Int J Cardiol; 2010 Mar; 139(3):276-82. PubMed ID: 19064293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription in patients with chronic heart failure and multimorbidity attended in primary care.
    Frigola-Capell E; Verdú-Rotellar JM; Comin-Colet J; Davins-Miralles J; Hermosilla E; Wensing M; Suñol R
    Qual Prim Care; 2013; 21(4):211-9. PubMed ID: 24041138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibitor use and mortality reduction: do controlled trial results equal clinical practice?
    Schade CP; Hannah KL; Rezek G; Brehm JG
    W V Med J; 2006; 102(1):304-6. PubMed ID: 16706321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibitor induced cough: experience in Siriraj Hospital.
    Buranakitjaroen P; Sriussadaporn S; Phoojaroenchanachai M; Sangprasert P; Saravich S
    J Med Assoc Thai; 2003 Jul; 86(7):647-54. PubMed ID: 12948260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.